[CT-Guided Interstitial Brachytherapy for Renal Tumours: A Narrative Review of Technique, Evidence, and Clinical Perspectives].
리뷰
1/5 보강
Renal cell carcinoma ranks among the most common malignant tumours.
APA
Rogowski P, Heimer M, et al. (2026). [CT-Guided Interstitial Brachytherapy for Renal Tumours: A Narrative Review of Technique, Evidence, and Clinical Perspectives].. Aktuelle Urologie, 57(2), 197-201. https://doi.org/10.1055/a-2750-5393
MLA
Rogowski P, et al.. "[CT-Guided Interstitial Brachytherapy for Renal Tumours: A Narrative Review of Technique, Evidence, and Clinical Perspectives].." Aktuelle Urologie, vol. 57, no. 2, 2026, pp. 197-201.
PMID
41500243 ↗
Abstract 한글 요약
Renal cell carcinoma ranks among the most common malignant tumours. However, a subset of patients is unsuitable for surgical treatment due to comorbidities, impaired renal function, or challenging tumour location. Thermal ablation techniques such as radiofrequency, microwave, or cryoablation are established alternatives but face limitations in centrally located tumours or lesions adjacent to major vessels. CT-guided interstitial high-dose-rate brachytherapy (HDR-BT) is a minimally invasive, precise, non-thermal ablation technique that can be applied irrespective of tumour size or location. A literature review identified three prospective studies on HDR-BT for renal tumours and renal-adjacent metastases, demonstrating local control rates of up to 95% with low toxicity and only infrequent clinically relevant renal impairment. HDR-BT thus addresses a therapeutic gap in inoperable or thermally challenging cases. Initial data are promising, and further clinical research may help to better define the role of HDR-BT within the overall therapeutic strategy.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.